These findings demonstrated that type-2 CD8+ T cells charaterize the peripheral immune profile in VAP while the fraction of CD45RA+ CD8+ Tregs in VAP is inferior to that in HC at baseline and during the AIT initiation phase. This evidence concerns the gene SGCG and ventilator-associated pneumonia.